MEXA  โ€ข  NASDAQ  โ€ข  DNTH US equities ยท completed weekly research
MEXA
๐Ÿ‡บ๐Ÿ‡ธ NASDAQ ยท Healthcare ยท Biotechnology

DNTH beta and relative strength

Dianthus Therapeutics Inc.

DNTH is weakening, but still above benchmark with lower sensitivity to QQQ.

Week ending Latest completed weekly edition
Next update 15:40 UK ยท after Stage Analysis
One-year beta 0.16Lower sensitivity ยท Falling
Movement explained 0%5% weekly correlation
Relative strength+56.35Weakening, but still above benchmark
Downside beta 0.97Upside beta -0.39
One-year excess return+332.0%357.2% stock ยท 25.2% benchmark
Directional participation

DNTH in rising and falling QQQ weeks

These percentages count what actually happened in completed weeks. They describe historical participation, not certainty about the next move.

Latest 52-week reading More dependable when the benchmark rises

The stock has joined rising benchmark weeks more consistently than falling ones.

63% of directional weeks moved the same way.
When QQQ rose72%

DNTH also rose in 72% of 29 rising benchmark weeks.

When QQQ fell52%

DNTH also fell in 52% of 23 falling benchmark weeks.

Market state now Range-bound market with active movement
-0.5% over 13 weeks21.8% volatility

After 26 earlier matches by market direction, directional participation is mixed.

Joined rising weeks60%
Joined falling weeks50%
Useful sample ยท 58% same-direction rate ยท -0.16 beta
Benchmark fit

DNTH sensitivity to QQQ

The benchmark relationship is weak and explains 0% of weekly movement over the latest year. Current beta is 0.16 and is falling.

Likely beta range-0.79 to 1.11

A wider range means the beta estimate is less precise.

Beta stability46/100

How consistently rolling beta has held its level and direction.

Annualised alpha+168.0%

The weekly regression intercept annualised; it is historical, not expected return.

Tracking error64.3%

Annualised volatility of returns above or below the benchmark.

Relationship directionRelationship broadly stable

-3.3 point change in movement explained across two distinct 26-week windows.

Beta and benchmark fitBeta is secondary evidence only
Weaker benchmark fitStronger benchmark fitLower sensitivityHigher sensitivity

The benchmark fit is too weak for the headline beta to be treated as a dependable description on its own.

Historical one-week sensitivity
If QQQ rises 1%-0.39%historically associated DNTH move
If QQQ falls 1%-0.97%historically associated DNTH move
Likely beta range -0.79 to 1.11 ยท width 1.90
Can the beta be trusted?Weak relationship
Movement explained0%
Stability46%
Directional agreement63%

Rolling beta

26-week estimates show whether market sensitivity is rising or falling.

Move across the chart to inspect a completed week.
Rolling betaMarket-like beta 1.00

Rolling relationship strength

Correlation shows direction; explained movement shows how useful the relationship has been.

Move across the chart to inspect a completed week.
CorrelationMovement explained
PeriodBetaCorrelationMovement explainedAlphaExcess returnTracking error
6 months-0.20-8%1%+183.3%+106.8%57.2%
1 year0.165%0%+168.0%+332.0%64.3%
2 years0.6622%5%+72.1%+242.6%60.2%
Relative strength

DNTH relative strength against QQQ

The score compares the stock/benchmark ratio with its trailing 52-week average. Above zero means the ratio is above trend; direction shows whether that advantage is building or fading.

Relative-strength trend

Current score 56.35 ยท 13-week change -6.62

Move across the chart to inspect a completed week.
Relative strengthZero baseline

Stock, benchmark and worthwhile peers

Each path starts at 100. Sector and industry appear only when their Market Structure indexes have enough constituents.

Move across the chart to inspect a completed week.
Sector ยท Healthcare+21.1 points

versus sector over 13 weeks ยท 948 constituents ยท 12% correlation

Industry ยท Biotechnology+23.6 points

versus industry over 13 weeks ยท 529 constituents ยท 18% correlation

Sensitivity to Healthcare0.38 beta

2% of weekly movement explained by the sector over one year.

Sensitivity to Biotechnology0.46 beta

3% of weekly movement explained by the industry over one year.

Return components

13-week and 52-week returns relative to QQQ

This is a return bridge, not a claim of cause. It starts with the benchmark return, then shows the difference added at sector, industry and ticker level.

Last 13 weeks+28.9 points vs benchmark
Broad market-0.5%
Sector difference+7.9%
Industry difference-2.5%
Ticker difference+23.6%

The largest source of relative strength was the ticker difference. DNTH returned 28.5%; QQQ returned -0.5%.

Last 52 weeks+332.0 points vs benchmark
Broad market+25.2%
Sector difference-15.5%
Industry difference+8.1%
Ticker difference+339.5%

The largest source of relative strength was the ticker difference. DNTH returned 357.2%; QQQ returned 25.2%.

Market conditions

DNTH in rising and falling benchmark weeks

Downside beta is higher than upside beta, so weak benchmark weeks have carried more sensitivity.

Upside beta-0.39159% upside capture
Downside beta0.97-157% downside capture
Current splitMore exposed in falling markets-1.36 beta gap
ConditionWeeksDNTH averageQQQ averageBetaBeat benchmark
Benchmark up29+3.64%+2.29%-0.3945%
Benchmark down23+2.88%-1.84%0.9761%
Strongest benchmark weeks10+3.49%+4.05%-0.1440%
Weakest benchmark weeks10+0.92%-3.12%-2.4670%
Quieter benchmark weeks26+5.58%+0.23%1.0758%
Historical extremes

Strongest and weakest 13-week relative periods

Distinct 13-week windows prevent one long move from filling the list with overlapping dates.

Strongest relative periods

2023-12-22 to 2024-03-15+280.6 pts

DNTH 288.0% ยท QQQ 7.3%

The return pattern shows that the industry added to the move, and the ticker moved beyond its peer backdrop.
2026-01-16 to 2026-04-10+137.4 pts

DNTH 135.1% ยท QQQ -2.4%

The return pattern shows that the industry added to the move, and the ticker moved beyond its peer backdrop.
2025-06-27 to 2025-09-19+104.1 pts

DNTH 118.0% ยท QQQ 13.9%

The return pattern shows that the industry added to the move, and the ticker moved beyond its peer backdrop.

Weakest relative periods

2023-09-22 to 2023-12-15-54.0 pts

DNTH -44.6% ยท QQQ 9.5%

The return pattern shows that the sector moved the same way, and the ticker moved beyond its peer backdrop.
2024-10-25 to 2025-01-17-36.8 pts

DNTH -31.2% ยท QQQ 5.7%

The return pattern shows that the sector moved the same way, and the industry added to the move, and the ticker moved beyond its peer backdrop.
2025-03-14 to 2025-06-06-29.5 pts

DNTH -21.6% ยท QQQ 7.9%

The return pattern shows that the sector moved the same way, and the ticker moved beyond its peer backdrop.
Pressure and timing

Drawdowns and lead/lag relationship

The strongest link is in the same week. Lead/lag evidence is treated as secondary because timing relationships can change quickly.

Drawdown from each rolling high

Worst available drawdown: DNTH -49.5% ยท QQQ -21.3%

Move across the chart to inspect a completed week.
DNTH drawdownQQQ drawdown
Ticker leads 2w
1%
Ticker leads 1w
-12%
Same week
14%
Benchmark leads 1w
9%
Benchmark leads 2w
-9%
Observable signals

Signals that would confirm or change the reading

These are conditions to monitor, not price targets or forecasts.

Relative strengthAbove the zero baseline

A fall through zero would show that the stock/benchmark ratio has moved below its trailing one-year average.

Up/down beta-1.36 upside-minus-downside gap

Downside beta is higher than upside beta. A narrowing gap would be the first sign of better asymmetry.

Exposure trendBeta is falling

Rising beta means broad-market moves are carrying more weight; falling beta means ticker-specific forces are carrying more weight.

Peer confirmation+23.6 points versus Biotechnology over 13 weeks

Strength shared by the peer group is broader; strength confined to the ticker is more company-specific and usually less stable.

Method and limits

Data and interpretation limits

Data
Completed weekly observations from 2023-09-22 to 2026-08-21 ยท 153 aligned weeks.
Current reading
52 weeks; rolling charts use 26 weeks.
Relative strength
Stock/benchmark ratio compared with its trailing 52-week average.
Peer evidence
At least 10 sector constituents and 5 industry constituents. Thin groups are excluded.
Boundary
Historical relationship analysis, not a forecast or a statement of cause. Historical relationships can break without warning.

Evidence context